Training Example: Cisbio – Review the Data, Give Your Score & Compare to the Real AI Evaluation

Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims: advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags: FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns: homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations: specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…

Cisbio

(https://cisbio.com) 📸 Data Snapshot: June 20, 2026

Analyze the raw signals below. How would a machine score this business’s credibility?

Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.

🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE Biology research & in vitro diagnostics solutions | Cisbio (https://cisbio.com)
Title

Biology research & in vitro diagnostics solutions | Cisbio

Meta

For more than 30 years, Cisbio has been serving the needs of the clinical and drug discovery communities, delivering a world-class portfolio of assays designed to help find answers faster. We

H1 Cisbio's leading life sciences and in vitro solutions are now part of Revvity's portfolio
H2 Life sciences
H2 In vitro diagnostics
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE · THIN (https://cisbio.com) Biology research & in vitro diagnostics solutions | Cisbio
[H1] Cisbio's leading life sciences and in vitro solutions are now part of Revvity's portfolio
Learn more at Revvity.com

[H2] Life sciences
We have moved our HTRF portfolio
Go to Revvity.com

[H2] In vitro diagnostics

Where precision and quality have created a foundation for trust over the past 30 years

Discover
361 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
0Review mentions (all pages)
0External proof links (all pages)
PageReviewsProof links
/ (home) 0 0
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage — no schema detected (entity gap)

Your Diagnosis

Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.

Information Density 0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence 0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof 0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint 0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority 0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score 0 / 100
💡 Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)

These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.

Information Density

Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.

Semantic Alignment

Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.

Trust & Proof

Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.

Commodity Fingerprint

Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.

Identity & Authority

Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.

Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.

B
BS Level
Medical Devices, Pharma & Biotech
40.7 Avg BS

Based on 784 businesses audited.

BS Detector

Medical Devices, Pharma & Biotech BS: Cisbio (cisbio.com)

https://cisbio.com 📍 Industry: Medical Devices, Pharma & Biotech
49 BS / 100

Cisbio is currently a digital ghost—a once-substantive biotech entity reduced to a 361-character shell. While the technical mention of HTRF saves it from a higher BS score, the site currently functions as an evidence-free traffic funnel for its parent company. It leverages a 30-year reputation as a signal without providing a single gram of modern substance to back it up.

Info Density Power-words vs. Substance ratio.
15
50% BS
Semantic Coherence Homepage promise vs. Sub-page reality.
4
20% BS
Trust & Proof Verifiable evidence vs. Trust Theatre.
12
60% BS
Commodity Fingerprint Detection of industry clichés/templates.
9
60% BS
Identity & Authority Expert verifiability & Schema depth.
9
60% BS

Immediately implement Organization schema with sameAs links to Revvity and historical Cisbio filings to bridge the identity gap. Replace the generic H2 body text under In Vitro Diagnostics with specific ISO 13485 or CE marking verification numbers. Provide a direct link to a peer-reviewed publication library or a technical specifications document for the HTRF portfolio to increase information density. Add a dedicated History or Legacy section with a dated timeline to substantiate the 30 years claim.

The site content perfectly aligns with the Medical Devices and Pharma & Biotech industry, specifically focusing on in vitro diagnostics and drug discovery. The mention of HTRF (Homogeneous Time Resolved Fluorescence) technology and life sciences portfolios confirms a high-level industry fit, though the content is currently in a transitional state.

“The score of 49 is driven primarily by the high Information Density penalty and the total lack of Trust and Proof evidence. The site's transition to Revvity has stripped away the technical substance that usually defines biotech sites, leaving behind a residue of generic industry clichés. The lack of structured data and high ratio of fluff-to-facts prevents it from achieving a Low BS rating despite its professional appearance.”

Verified Analysis Date: June 20, 2026 © 1EuroSEO Independent Evaluator — Non-Sponsored Result